Literature DB >> 19409893

Cytokeratins 8 and 18 in adult human corneal endothelium.

Stanislava Merjava1, Ales Neuwirth, Vaclav Mandys, Katerina Jirsova.   

Abstract

The aim of this study was to determine if cytokeratins (CKs) 8 and 18--typical epithelial cell markers--are constitutively expressed in adult human corneal endothelium. Cryosections, paraffin-embedded sections and corneal endothelial imprints obtained from eleven adult human corneal discs not suitable for transplantation were used. Different fixative solutions were applied before indirect immunofluorescent or enzymatic staining was performed with antibodies against CK8 (Chemicon), CK18 (Dako and Sigma) and CK8/18 (Novocastra). Semi-quantitative RT-PCR and Western blotting (mRNA or proteins were isolated from Millicell membranes) were used to determine cytokeratin mRNA and protein levels. Approximately 50% of the corneal endothelial cells were positive for CK8 (Chemicon), CK18 (Sigma) and the CK pair 8/18 (Novocastra) in the endothelium when acetone was used for fixation. Four and 52% CK18-positive cells were observed using immunofluorescent and enzymatic immunohistochemistry, respectively, when the CK18 antibody from Dako was used. No signal was detected when 4% formalin or 10% paraformaldehyde was used as a fixative, irrespective of the antibody used. CK8 and CK18 proteins and mRNAs were detected in the endothelium of all tested corneas by Western blotting or semi-quantitative RT-PCR, respectively. We detected both CK8 and CK18 in the endothelium of all specimens at both the protein and mRNA levels. These results clearly demonstrate that cells of the corneal endothelium express CKs 8 and 18 and share some features with simple epithelia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19409893     DOI: 10.1016/j.exer.2009.04.009

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  13 in total

1.  Differentiation potential of limbal fibroblasts and bone marrow mesenchymal stem cells to corneal epithelial cells.

Authors:  Kishore Reddy Katikireddy; Reza Dana; Ula V Jurkunas
Journal:  Stem Cells       Date:  2014-03       Impact factor: 6.277

2.  Lim1/LIM1 is expressed in developing and adult mouse and human endometrium.

Authors:  Louie Ye; Jemma Evans; Caroline E Gargett
Journal:  Histochem Cell Biol       Date:  2012-01-10       Impact factor: 4.304

3.  The OV-TL 12/30 clone of anti-cytokeratin 7 antibody as a new marker of corneal conjunctivalization in patients with limbal stem cell deficiency.

Authors:  Katerina Jirsova; Lubica Dudakova; Sarka Kalasova; Viera Vesela; Stanislava Merjava
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

4.  MUC16 as a sensitive and specific marker for epithelial downgrowth.

Authors:  Vicky C Pai; Ben J Glasgow
Journal:  Arch Ophthalmol       Date:  2010-11

5.  Cultivation and characterization of cornea limbal epithelial stem cells on lens capsule in animal material-free medium.

Authors:  Réka Albert; Zoltán Veréb; Krisztián Csomós; Morten C Moe; Erik O Johnsen; Ole Kristoffer Olstad; Bjørn Nicolaissen; Eva Rajnavölgyi; László Fésüs; András Berta; Goran Petrovski
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

6.  Generation of human female reproductive tract epithelium from human embryonic stem cells.

Authors:  Louie Ye; Robyn Mayberry; Camden Y Lo; Kara L Britt; Edouard G Stanley; Andrew G Elefanty; Caroline E Gargett
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

7.  Attempting to distinguish between endogenous and contaminating cytokeratins in a corneal proteomic study.

Authors:  Mikkel Lyngholm; Henrik Vorum; Kim Nielsen; Niels Ehlers; Bent Honoré
Journal:  BMC Ophthalmol       Date:  2011-01-27       Impact factor: 2.209

Review 8.  Progenitors for the corneal endothelium and trabecular meshwork: a potential source for personalized stem cell therapy in corneal endothelial diseases and glaucoma.

Authors:  Wing Yan Yu; Carl Sheridan; Ian Grierson; Sharon Mason; Victoria Kearns; Amy Cheuk Yin Lo; David Wong
Journal:  J Biomed Biotechnol       Date:  2011-12-06

9.  Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial.

Authors:  J Cummings; M Zweifel; N Smith; P Ross; J Peters; G Rustin; P Price; M R Middleton; T Ward; C Dive
Journal:  Br J Cancer       Date:  2012-04-26       Impact factor: 7.640

Review 10.  Use of Mesothelial Cells and Biological Matrices for Tissue Engineering of Simple Epithelium Surrogates.

Authors:  Christian Claude Lachaud; Berta Rodriguez-Campins; Abdelkrim Hmadcha; Bernat Soria
Journal:  Front Bioeng Biotechnol       Date:  2015-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.